SEC Form 4 · accession 0001140361-15-044823
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles S. Ryan
Director
Period of report
Dec 7, 2015
Accepted (ET)
Dec 17, 2015 · 10:25 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2015 | P | 6,250 | $4.00 | A | 16,250 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant | $4.00 | Dec 7, 2015 | P | 6,250 | A | Dec 7, 2015 | Nov 12, 2020 | Common Stock | 6,250 | 6,250 | D |
| OptionF2 | $8.00 | holding | — | — | — | — | Apr 6, 2025 | Common Stock | 15,000 | 15,000 | D |
| Warrant | $15.00 | holding | — | — | — | May 8, 2015 | May 8, 2020 | Common Stock | 2,500 | 2,500 | D |
Explanation of responses
- F1Common Stock and Warrant were issued to Reporting Person in exchange for cancellation of indebtedness due from Issuer in the amount of $25,000.
- F2The option vests to the extent of 5,000 shares on each of April 6, 2016, 2017 and 2018.